We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Topic: Diabetes Research Network Subtopic: Type 2 Disease: Insulin switch, Metabolic
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Not provided at time of registration
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Patients on sulphonylureas or thiazolidinediones2. Proliferative retinopathy that has required acute treatment within the last six months3. Impaired hepatic or renal functions4. Cardiac problems5. Uncontrolled hypertension (treated or untreated)6. Mental incapacity, unwillingness or a language barrier precluding adequate understanding or co-operation
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
Dr
Benjamin
Sheldon
-
no@email.provided
The study is sponsored by University of Surrey (UK) and funded by Learning about Insulin Bursary for Research and Awareness (LIBRA) (UK).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
